7/23/2010

A U.S. study suggests that patients with a low level of LDL, or "bad," cholesterol as a result of using a high-dose statin, such as AstraZeneca's Crestor, might not benefit from a high level of HDL, or "good," cholesterol. The finding suggests that "once on a high-dose statin, it is unclear if HDL cholesterol remains an important determinant of residual risk" of cardiovascular disease, the lead author said.

Full Story:
HealthDay News

Related Summaries